Furthermore, HAMI 3379 is found to alleviate post-stroke depression as a CysLT (2)R antagonist by inhibiting NLRP3-mediated pyroptosis in gerbils (Zhou et al., 2022). Here, NLRP3 is linked to depressive disorder.